Publication | Closed Access

Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy

Hematological MalignancyTranslational MedicineMedicineAcute Myeloid LeukemiaSevere Crs/icansImmunologyHematologyMixed-phenotype Acute LeukemiaMyeloid NeoplasiaMalignant Blood DisorderAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation OncologyModified EasixCancer ResearchHealth Sciences